��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title BAF312 Dose-Titration Scheme Significantly Attenuates Initial Heart Rate Reducing Effects in Healthy Subjects

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 240

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Faria S. Amjad, MD (Medstar Georgetown University Hospital)	Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. An immediate family member of Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myer Squibb. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Piramal.
	No disclosure on file
	No disclosure on file
Erik Wallstroem, MD, PhD (Sanofi)	Dr. Wallstroem has received personal compensation for serving as an employee of Sanofi. Dr. Wallstroem has stock in Sanofi. Dr. Wallstroem has received intellectual property interests from a discovery or technology relating to health care.
Donald Johns, MD (Axon Guidance LLC)	No disclosure on file